Benign prostatic hyperplasia (BPH) research hub
3 indexed studies · 1 currently recruiting
- ongoing, recruitingHuman Pharmacology (Phase I)- Bioequivalence Study
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Tamsulosin Hydrochloride Capsules USP 0.4 mg, manufactured by Sun Pharmaceutical Industries Limited, India with Tamsulosin Hydrochloride extended-release capsules 0.4 mg, Product of Geolab Indústria Farmacêutica S/A, VP. 1B QD.08-B Modules 01 to 08, DAIA - Anápolis – GO, in healthy adult, human male subjects under fasting condition.
This study compares two versions of a medicine called tamsulosin in healthy men. It checks if a new version works the same as an existing one, specifically looking at how the body absorbs them when taken on an empty stomach.
Romania - recruitingNA
Post-Market Study to Assess iTind Safety in Comparison to UroLift
This study compares the safety and how well two treatments, iTind and UroLift, work for men with an enlarged prostate. Both help improve common bladder problems. Researchers want to see which one is safer and more effective for relieving symptoms like frequent urination or difficulty peeing.
United States · United Kingdom - ongoing, recruitingHuman Pharmacology (Phase I)- Bioequivalence Study
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Tamsulosin Hydrochloride Capsules USP 0.4 mg, manufactured by Sun Pharmaceutical Industries Limited, India with Tamsulosin Hydrochloride extended-release capsules 0.4 mg, Product of Geolab Indústria Farmacêutica S/A, VP. 1B QD.08-B Modules 01 to 08, DAIA - Anápolis – GO, in healthy adult, human male subjects under fed condition.
This study compares two versions of a medicine called Tamsulosin Hydrochloride, often used for prostate enlargement. It checks if they act the same way in healthy men after eating, to ensure they have the same effect.
Romania